Drug intelligence / Profile preview

budesonide + triamcinolone

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Inhalation, Oral, Rectal, Intranasal, Topical, Ophthalmic, Intraarticular, Intramuscular
01

Overview

Budesonide + triamcinolone is a combination of two synthetic corticosteroids, each with potent anti-inflammatory and immunosuppressive properties. Budesonide is primarily used to treat inflammatory diseases affecting the airways and gastrointestinal tract, such as asthma, COPD, Crohn's disease, and ulcerative colitis. Triamcinolone is used for a wide range of inflammatory conditions including allergic disorders, arthritis, skin diseases, ocular inflammation, and certain autoimmune conditions. Both drugs act by binding to the glucocorticoid receptor and modulating gene expression to suppress pro-inflammatory cytokines and mediators. The combination would theoretically provide additive or synergistic anti-inflammatory effects but is not a standard or widely marketed fixed-dose product.

02

Targets

Beyond the preview

Go deeper on budesonide + triamcinolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on budesonide + triamcinolone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call